So far, most genetic studies associated with 22q11DS focused on the COMT gene, which plays an important role in the degradation of dopamine [29], and to a lesser extent on the PRODH gene, which catalyses the conversion of proline to glutamate [31]. This evidence concerns the gene PRODH and 22q11.2 deletion syndrome.